Open-house contract for Aclidiniumbromid/Formoterol
Originaltitel der Bekanntmachung
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-06 - Aclidiniumbromid/Formoterol (Wirkstoffkombination)
Opportunity Score
Warum diese Bewertung?
Chance
45 / 100
Komplexität
58 / 100
Risikofaktoren
The notice says offers/contracts cannot be submitted through the portal and must be sent by email with qualified electr...
Only pharmaceutical undertakings meeting the AMG-based eligibility conditions and exclusion declarations may participat...
Submission deadline in 2 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Aug 2026
- Conclude rebate contracts under § 130c SGB V for the product combination Aclidiniumbromid/Formoterol.
- Provide supplies of the relevant pharmaceutical products under an open-house model.
Vollständige Zusammenfassung anzeigen
Open-house supply arrangement in Germany for the pharmaceutical product combination Aclidiniumbromid/Formoterol, led by Techniker Krankenkasse. The notice states that contracts may be concluded with all suitable pharmaceutical companies under uniform conditions, without individual negotiations or exclusivity. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, and the participation documents are only available to companies that market or credibly intend to market the relevant product. No contract value is stated.
Risiken
The notice says offers/contracts cannot be submitted through the portal and must be sent by email with qualified electr...
Only pharmaceutical undertakings meeting the AMG-based eligibility conditions and exclusion declarations may participat...
Submission deadline in 2 days
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Applicant must be a pharmaceutical undertaking in the sense of § 4(18) AMG for the offered medicinal products.
- Applicant must have its seat in the AMG territory, another EU Member State, or another EEA State.
- Applicant must have a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Hamburg, DEU
Website
Kennung
992-80116-93
Tätigkeit
Health
Lose (1)
LOT-0001
Open-house contract for Aclidiniumbromid/Formoterol
Supply lot for the medicinal product combination Aclidiniumbromid/Formoterol under an open-house rebate contract. The contract is open to all eligible pharmaceutical companies, with no exclusivity and no individual negotiation. Lot information comes from structured data and the notice text.
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Open-house procedure with uniform conditions
the stated award criteria field has no substantive criterion value and is described in the notice as having no further meaning.
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Open House Originale Rabattverträge 2024-06 - Aclidiniumbromid/Formoterol (Wirkstoffkombination)
Originale TED-Beschreibung
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c SGB V zur Wirkstoffkombination Aclidiniumbromid/Formoterol zu schließen.
Vergabedetails
- Veröffentlichungsdatum
- 15 Jul 2024
- Sprachen
- German
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 422415-2024
Dokumente (1)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
45 / 100
Komplexität
58 / 100
Risikofaktoren
The notice says offers/contracts cannot be submitted through the portal and must be sent by email with qualified electr...
Only pharmaceutical undertakings meeting the AMG-based eligibility conditions and exclusion declarations may participat...
Submission deadline in 2 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications